A "performance audit" by Moss-Adams, a Seattle business consulting firm, made 12 recommendations for the $3 billion research enterprise. One of the 12 was to implement the unfulfilled recommendations made by Moss-Adams three years ago. Seven of the 24 from that audit still need more action, the firm said.
On Thursday, the agency's governing board is scheduled to discuss the latest audit at a meeting in Berkeley. The study is required by state law every three years. The agency's scientific performance, however, is specifically excluded from being examined. Moss-Adams is scheduled to receive $230,000 from the agency for the audit, which was for the 2013-14 year.
On Sunday, the California Stem Cell Report covered the deficiencies involving disclosures of the financial interests of grant reviewers.
Other areas of concern included the need for better tracking of intellectual property that could mean royalties for the state, more timely review of progress reports from grantees, more timely, formal evaluation of employees and keeping up-to-date on technology related to grant management and agency efficiency.
Under the subject of "commendations," Moss-Adams said that CIRM had "many strengths." The consultant said the agency has made "significant strides" in three areas: the grant management system, grants process improvements and "organizational culture."
Moss-Adams said more work was needed on implementing the seven recommendations from three years ago, including those involving IP, the transition plan to deal with the possible demise of the agency and a grants outcome database.